Fingerprint
Dive into the research topics of 'Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms
Farhad Ravandi*, Ahmed Aribi, Susan O'Brien, Stefan Faderl, Dan Jones, Alessandra Ferrajoli, Xuelin Huang, Sergernne York, Sherry Pierce, William Wierda, Dimitrios Kontoyiannis, Srdan Verstovsek, Barbara Pro, Luis Fayad, Michael Keating, Hagop Kantarjian
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations